Cancer stem cells can be regulated by aberrant miRNA expression, and miR‐124 and JAMA are involved in the development of stem‐like traits; however, the role of miR‐124 in NPC CSCs has not been clearly defined. This evidence concerns the gene F11R and nasopharyngeal carcinoma.